Latest Insider Transactions at Organicell Regenerative Medicine, Inc. (OCEL)
This section provides a real-time view of insider transactions for Organicell Regenerative Medicine, Inc. (OCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organicell Regenerative Medicine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organicell Regenerative Medicine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.15 P/Share
|
|
Jun 09
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
80,000
-0.03%
|
$0
$0.15 P/Share
|
|
Jun 08
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 08
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 08
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.04%
|
$0
$0.13 P/Share
|
|
Jun 08
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.06%
|
$0
$0.13 P/Share
|
|
Jun 07
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.13 P/Share
|
|
Jun 07
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.12 P/Share
|
|
Jun 07
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.04%
|
$0
$0.12 P/Share
|
|
Jun 07
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.06%
|
$0
$0.12 P/Share
|
|
Jun 04
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 04
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-0.02%
|
$0
$0.14 P/Share
|
|
Jun 04
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.14 P/Share
|
|
Jun 04
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100,800
-0.04%
|
$0
$0.14 P/Share
|
|
Jun 02
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.16 P/Share
|
|
Jun 02
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.06%
|
$0
$0.17 P/Share
|
|
Jun 02
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.17 P/Share
|
|
Jun 02
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
90,000
-0.03%
|
$0
$0.17 P/Share
|
|
Jun 01
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.19 P/Share
|
|
Jun 01
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.19 P/Share
|
|
Jun 01
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.19 P/Share
|
|
Jun 01
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.19 P/Share
|
|
May 28
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 28
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 28
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.18 P/Share
|
|
May 28
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
42,749
-0.05%
|
$0
$0.18 P/Share
|
|
May 27
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.02%
|
$0
$0.18 P/Share
|
|
May 27
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-0.02%
|
$0
$0.18 P/Share
|
|
May 27
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.04%
|
$0
$0.18 P/Share
|
|
May 27
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
57,251
-0.04%
|
$0
$0.18 P/Share
|
|
May 26
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.02%
|
$0
$0.19 P/Share
|
|
May 26
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.19 P/Share
|
|
May 26
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.03%
|
$0
$0.19 P/Share
|
|
May 26
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.05%
|
$0
$0.19 P/Share
|
|
May 25
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.2 P/Share
|
|
May 25
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.2 P/Share
|
|
May 25
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.04%
|
$0
$0.2 P/Share
|
|
May 25
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.06%
|
$0
$0.2 P/Share
|
|
May 24
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 24
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 24
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.18 P/Share
|
|
May 24
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.06%
|
$0
$0.18 P/Share
|
|
May 21
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 21
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-0.03%
|
$0
$0.18 P/Share
|
|
May 21
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.04%
|
$0
$0.18 P/Share
|
|
May 21
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,504
-0.01%
|
$0
$0.18 P/Share
|
|
May 20
2021
|
Albert Mitrani Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.03%
|
$0
$0.2 P/Share
|
|
May 20
2021
|
George Craig Shapiro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.12%
|
$0
$0.19 P/Share
|
|
May 20
2021
|
Maria Ines Mitrani Chief Science Officer |
SELL
Open market or private sale
|
Direct |
100,000
-0.04%
|
$0
$0.19 P/Share
|
|
May 20
2021
|
Ian T Bothwell Interim CEO & CFO |
SELL
Open market or private sale
|
Direct |
76,274
-0.03%
|
$0
$0.19 P/Share
|